Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- PMID: 21514248
- PMCID: PMC3220946
- DOI: 10.1016/j.jalz.2011.03.003
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Abstract
The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia. This long "preclinical" phase of AD would provide a critical opportunity for therapeutic intervention; however, we need to further elucidate the link between the pathological cascade of AD and the emergence of clinical symptoms. The National Institute on Aging and the Alzheimer's Association convened an international workgroup to review the biomarker, epidemiological, and neuropsychological evidence, and to develop recommendations to determine the factors which best predict the risk of progression from "normal" cognition to mild cognitive impairment and AD dementia. We propose a conceptual framework and operational research criteria, based on the prevailing scientific evidence to date, to test and refine these models with longitudinal clinical research studies. These recommendations are solely intended for research purposes and do not have any clinical implications at this time. It is hoped that these recommendations will provide a common rubric to advance the study of preclinical AD, and ultimately, aid the field in moving toward earlier intervention at a stage of AD when some disease-modifying therapies may be most efficacious.
Copyright © 2011. Published by Elsevier Inc.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3220946/bin/nihms329556f1.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3220946/bin/nihms329556f2.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3220946/bin/nihms329556f3.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3220946/bin/nihms329556f4.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3220946/bin/nihms329556f5.gif)
Comment in
-
Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." New criteria for a new era.Alzheimers Dement. 2011 May;7(3):328-9. doi: 10.1016/j.jalz.2011.03.007. Alzheimers Dement. 2011. PMID: 21575873 No abstract available.
Similar articles
-
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Rev Neurol (Paris). 2012. PMID: 22579080 Review. French.
-
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004. Epub 2011 Apr 21. Alzheimers Dement. 2011. PMID: 21514247 Free PMC article.
-
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21. Alzheimers Dement. 2011. PMID: 21514249 Free PMC article.
-
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21. Alzheimers Dement. 2011. PMID: 21514250 Free PMC article.
-
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018. Alzheimers Dement. 2018. PMID: 29653606 Free PMC article. Review.
Cited by
-
Proteomic changes in Alzheimer disease associated with progressive Aβ plaque and tau tangle pathologies.Nat Neurosci. 2024 Aug 26. doi: 10.1038/s41593-024-01737-w. Online ahead of print. Nat Neurosci. 2024. PMID: 39187705
-
The memory binding test can anticipate Alzheimer's disease diagnosis at an early preclinical stage: a longitudinal study in the INSIGHTpreAD cohort.Front Aging Neurosci. 2024 Aug 8;16:1414419. doi: 10.3389/fnagi.2024.1414419. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39175810 Free PMC article.
-
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic.Alzheimers Res Ther. 2024 Aug 21;16(1):190. doi: 10.1186/s13195-024-01545-1. Alzheimers Res Ther. 2024. PMID: 39169442 Free PMC article.
-
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research.Neurology. 2024 Sep 10;103(5):e209753. doi: 10.1212/WNL.0000000000209753. Epub 2024 Aug 21. Neurology. 2024. PMID: 39167736
-
Altered functional connectivity of primary olfactory cortex-hippocampus-frontal cortex in subjective cognitive decline during odor stimulation.Hum Brain Mapp. 2024 Aug 15;45(12):e26814. doi: 10.1002/hbm.26814. Hum Brain Mapp. 2024. PMID: 39163575 Free PMC article.
References
-
- Morris JC. Early-stage and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord. 2005;19:163–5. - PubMed
-
- Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010;9:1118–27. - PubMed
-
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270–9. - PMC - PubMed
-
- McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging– Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263–9. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical